Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001048477-25-000090
Filing Date
2025-08-05
Accepted
2025-08-05 13:03:48
Documents
73
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bmrn-20250630.htm   iXBRL 10-Q 1557051
2 EX-10.2 bmrn-ex102x2017equityincen.htm EX-10.2 204887
3 EX-31.1 bmrn-exx311xq22025.htm EX-31.1 9227
4 EX-31.2 bmrn-exx312xq22025.htm EX-31.2 9240
5 EX-32.1 bmrn-exx321xq22025.htm EX-32.1 5132
  Complete submission text file 0001048477-25-000090.txt   7631855

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmrn-20250630.xsd EX-101.SCH 42137
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmrn-20250630_cal.xml EX-101.CAL 72994
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmrn-20250630_def.xml EX-101.DEF 203234
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmrn-20250630_lab.xml EX-101.LAB 561213
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmrn-20250630_pre.xml EX-101.PRE 388189
76 EXTRACTED XBRL INSTANCE DOCUMENT bmrn-20250630_htm.xml XML 1210861
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 251184000
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)